Cytegen ^Company

CyteGen team members hold the first patents on the genetic markers of aging and combined with recent advances in systems biology approaches to aging has given CyteGen unique insights into the different aging pathways. Using data analytics, the CyteGen team integrates genomics, proteomics, and biochemical data from these pathways to discover new therapies that extend healthspan. CyteGen scientists have discovered new pathways that target the energy producing machine of the human body, the mitochondrion. Through a proprietary model and approach, CyteGen has identified means to stimulate mitochondrial fitness and is commercializing its discoverie into treatments.